Stockreport

IO Biotech to Present at Jefferies Global Healthcare Conference

IO Biotech, Inc.  (IOBT) 
PDF NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer [Read more]